Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Exosomes could be a promising way to help repair skin and treat skin disorders.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Two main types of fibroblasts with unique functions and additional subtypes were identified in human skin.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

A genetic marker linked to a type of hair loss was found in most patients studied.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Dermal papilla cells help wounds heal better and can potentially grow new hair.

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

Substance from human umbilical cord blood cells promotes hair growth.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

3D culture helps maintain hair growth cells better than 2D culture and identifies key genes for potential hair loss treatments.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Different substances affect hair and skin cell growth in various ways.